Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEVG.L Share News (EVG)

  • There is currently no data for EVG

Record breaking year at Evolution

Thu, 25th Mar 2010 08:25
2009 was a record breaking year on many fronts for investment management firm Evolution Group.Group income, private client income, investment banking income and assets under management all hit new highs.Total income more than doubled to £129.4m in 2009 from £63.9m, with investment banking income soaring 183% to £87m while private client income rose 23% to £42.4m.Assets under management jumped 37% to a record level of £5.2bn from £3.8bn the year before. Fund inflows at £322m were down from £550m the year before, but the number of private client accounts grew from 11,803 to 14,343. Statutory profit before tax was £11.1m, compared to a loss of £12.7m the year before. The company’s own adjusted profit before tax measurement showed profitability improving to £18,4m from £2.9m in 2008. ‘While activity levels last year remained depressed and investor sentiment proved highly sensitive to risk and volatility, the group nevertheless delivered an extremely impressive financial performance, with significant growth in both income and profit,’ said Martin Gray, chairman of Evolution.The final dividend has been increased by 34% to 1.70p, making the full year dividend 2.50p, up 24% on 2008’s level.

Related News

TRADING UPDATES: Norcros sells Johnson Tiles UK; Trifast trading well
25 Apr 2024

TRADING UPDATES: Norcros sells Johnson Tiles UK; Trifast trading well

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

TRADING UPDATES: Northcoders launches bootcamp; Schroder invests
4 Apr 2024

TRADING UPDATES: Northcoders launches bootcamp; Schroder invests

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

EARNINGS AND TRADING: Ten Lifestyle sees profit up but sales flat
19 Mar 2024

EARNINGS AND TRADING: Ten Lifestyle sees profit up but sales flat

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Tuesday and not separately reporte...

EVG.L News

IN BRIEF: Evgen Pharma Recruits Patients For STAR-Covid-19 Trial
19 Jan 2021

IN BRIEF: Evgen Pharma Recruits Patients For STAR-Covid-19 Trial

IN BRIEF: Evgen Pharma Recruits Patients For STAR-Covid-19 Trial

UK EARNINGS SUMMARY: Character Group Lowers Dividend As Profit Drops
10 Dec 2020

UK EARNINGS SUMMARY: Character Group Lowers Dividend As Profit Drops

UK EARNINGS SUMMARY: Character Group Lowers Dividend As Profit Drops

Evgen Pharma performs in line with forecasts in first half
10 Dec 2020

Evgen Pharma performs in line with forecasts in first half

(Sharecast News) - Clinical-stage drug development company Evgen Pharma reported financial performance in line with its expectations in its first half...

IN BRIEF: Evgen Pharma Doses First Patient In Lead Candidate Trial
23 Nov 2020

IN BRIEF: Evgen Pharma Doses First Patient In Lead Candidate Trial

IN BRIEF: Evgen Pharma Doses First Patient In Lead Candidate Trial

Evgen doses first patients in 'STAR' respiratory trial
23 Nov 2020

Evgen doses first patients in 'STAR' respiratory trial

(Sharecast News) - Clinical-stage drug development company Evgen Pharma announced on Monday that the first patient had now been enrolled and dosed in ...

IN BRIEF: Evgen Pharma About To Begin SFX-01 Trial Recruitment
11 Nov 2020

IN BRIEF: Evgen Pharma About To Begin SFX-01 Trial Recruitment

IN BRIEF: Evgen Pharma About To Begin SFX-01 Trial Recruitment

Evgen gets full approval for SFX-01 trial in Covid-19 patients
23 Oct 2020

Evgen gets full approval for SFX-01 trial in Covid-19 patients

(Sharecast News) - Clinical-stage drug development company Evgen Pharma announced on Friday that all necessary regulatory approvals had now been recei...

Shares In Evgen Pharma Rise On Approval For SFX-01 Trial
23 Oct 2020

Shares In Evgen Pharma Rise On Approval For SFX-01 Trial

Shares In Evgen Pharma Rise On Approval For SFX-01 Trial